We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTNR
2676
DELISTED
Vertex Energy, Inc
VTNR
| $910K | ﹤0.01% |
146,748
-17,784
| -11% | -$133K |
|
2677
EVgo
EVGO
$229M
| $909K | ﹤0.01% |
203,172
-29,608
| -13% | -$191K |
|
2678
Universal Electronics
UEIC
$61.3M
| $907K | ﹤0.01% |
43,579
-6,167
| -12% | -$128K |
|
2679
Monte Rosa Therapeutics
GLUE
$1.35B
| $905K | ﹤0.01% |
118,798
-13,849
| -10% | -$115K |
|
|
GPMT
2680
Granite Point Mortgage Trust
GPMT
$61.2M
| $903K | ﹤0.01% |
168,323
-24,732
| -13% | -$161K |
|
2681
Utah Medical Products
UTMD
$225M
| $901K | ﹤0.01% |
8,964
-810
| -8% | -$73.9K |
|
2682
BrightView Holdings
BV
$1.07B
| $898K | ﹤0.01% |
130,327
-21,637
| -14% | -$167K |
|
2683
Adicet Bio
ACET
$74.7M
| $894K | ﹤0.01% |
6,251
-802
| -11% | -$200K |
|
2684
Park Aerospace
PKE
$819M
| $893K | ﹤0.01% |
66,623
-10,545
| -14% | -$128K |
|
2685
PLAYSTUDIOS Inc
MYPS
$90.1M
| $892K | ﹤0.01% |
229,867
-25,100
| -10% | -$101K |
|
2686
Upland Software
UPLD
$15.4M
| $890K | ﹤0.01% |
12,484
+2,358
| +23% | +$176K |
|
2687
Omega Flex
OFLX
$312M
| $889K | ﹤0.01% |
9,525
-526
| -5% | -$49.8K |
|
2688
Dream Finders Homes
DFH
$1.36B
| $885K | ﹤0.01% |
102,208
+29,560
| +41% | +$296K |
|
|
SFIX
2689
Stitch Fix
SFIX
$560M
| $884K | ﹤0.01% |
284,091
-23,218
| -8% | -$86.8K |
|
2690
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $877K | ﹤0.01% |
26,846
-13,491
| -33% | -$427K |
|
|
TDAY
2691
USA Today Co
TDAY
$1.06B
| $875K | ﹤0.01% |
430,734
-261,620
| -38% | -$502K |
|
2692
Lands' End
LE
$403M
| $873K | ﹤0.01% |
115,081
+4,642
| +4% | +$42.5K |
|
2693
Tredegar Corp
TG
$310M
| $873K | ﹤0.01% |
85,407
-13,470
| -14% | -$141K |
|
2694
Outlook Therapeutics
OTLK
$191M
| $871K | ﹤0.01% |
40,319
-1,444
| -3% | -$31.4K |
|
2695
Riley Exploration Permian
REPX
$758M
| $871K | ﹤0.01% |
29,601
+6,990
| +31% | +$199K |
|
|
ALBO
2696
DELISTED
Albireo Pharma Inc
ALBO
| $870K | ﹤0.01% |
40,260
-52,803
| -57% | -$1.12M |
|
|
CMAX
2697
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $870K | ﹤0.01% |
7,942
+734
| +10% | +$110K |
|
|
TSVT
2698
DELISTED
2seventy bio
TSVT
| $869K | ﹤0.01% |
92,712
-17,709
| -16% | -$250K |
|
|
KBAL
2699
DELISTED
Kimball International
KBAL
| $869K | ﹤0.01% |
133,733
-22,202
| -14% | -$152K |
|
2700
Universal Logistics Holdings
ULH
$529M
| $863K | ﹤0.01% |
25,812
-852
| -3% | -$29.8K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.